Switzerland: Sophia Genetics closes US IPO at US$18 per share to raise US$234m

Sophia Genetics, a healthcare technology company dedicated to establishing the practice of data driven medicine as the standard of care and for life sciences research priced its IPO of 13 million ordinary shares listed on Nasdaq at US$18 per share. The gross proceeds from the offering are expected to be approximately US$234m. There is a…

You must be a HMI Subscriber to view this content.

Subscribe Now »